PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Global Health, School of Public Health, Boston University, Boston, Massachusetts, USA.\', \'Health Economics and Epidemiology Research Office, Department of Internal Medicine, School of Clinical Medicine, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.\', \'Massachusetts College of Pharmacy and Health Sciences, Boston, Massachusetts, USA.\', \'Modelling and Simulation Hub, Africa, Department of Statistical Sciences, University of Cape Town, Cape Town, South Africa.\', \'Centre for Tropical Medicine and Global Health, Nuffield Department of Medicine, University of Oxford, Oxford, United Kingdom.\', \'South African Department of Science and Innovation-National Research Foundation Centre of Excellence in Epidemiological Modelling and Analysis (SACEMA), Stellenbosch University, Stellenbosch, South Africa.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.1093/cid/ciaa937
?:doi
?:hasPublicationType
?:journal
  • Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
is ?:pmid of
?:pmid
?:pmid
  • 32628744
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
?:title
  • The Role of Remdesivir in South Africa: Preventing COVID-19 Deaths Through Increasing Intensive Care Unit Capacity.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all